You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 13, 2025

CHEMET Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Chemet, and when can generic versions of Chemet launch?

Chemet is a drug marketed by Recordati Rare and is included in one NDA.

The generic ingredient in CHEMET is succimer. There are two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the succimer profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for CHEMET?
  • What are the global sales for CHEMET?
  • What is Average Wholesale Price for CHEMET?
Summary for CHEMET
Drug patent expirations by year for CHEMET
Drug Prices for CHEMET

See drug prices for CHEMET

Recent Clinical Trials for CHEMET

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
M.D. Anderson Cancer CenterPhase 1
National Cancer Institute (NCI)Phase 1

See all CHEMET clinical trials

Pharmacology for CHEMET
Drug ClassLead Chelator
Mechanism of ActionLead Chelating Activity

US Patents and Regulatory Information for CHEMET

ApplicantTradenameGeneric NameDosageNDAApproval DateTETypeRLDRSPatent No.Patent ExpirationProductSubstanceDelist Req.Exclusivity Expiration
Recordati Rare CHEMET succimer CAPSULE;ORAL 019998-002 Jan 30, 1991 RX Yes Yes ⤷  Try for Free ⤷  Try for Free ⤷  Try for Free
>Applicant>Tradename>Generic Name>Dosage>NDA>Approval Date>TE>Type>RLD>RS>Patent No.>Patent Expiration>Product>Substance>Delist Req.>Exclusivity Expiration
Showing 1 to 1 of 1 entries

Market Dynamics and Financial Trajectory for the Pharmaceutical Chemicals Market

Introduction

The pharmaceutical chemicals market is a vibrant and rapidly evolving sector, driven by several key factors that influence its growth and financial performance. Here, we will delve into the market dynamics, growth drivers, and financial trajectory of this industry, with a focus on the broader context that affects companies like those involved in the production and distribution of pharmaceutical chemicals.

Market Size and Growth

As of 2022, the pharmaceutical chemicals market was valued at US$ 204.3 billion. It is projected to grow at a Compound Annual Growth Rate (CAGR) of 5.8% from 2023 to 2031, reaching a value of US$ 339.3 billion by 2031[1][4].

Growth Drivers

Several factors are driving the growth of the pharmaceutical chemicals market:

Increasing Healthcare Spending

Global healthcare spending continues to rise, leading to an increased demand for pharmaceuticals and, by extension, pharmaceutical chemicals. Investments in healthcare infrastructure by both public and private sectors further boost this demand[1][4].

Advancements in Technology

The integration of cutting-edge technologies such as 3D printing, ongoing manufacturing, digital technology, data analytics, and artificial intelligence into drug discovery and development processes is expected to enhance productivity and efficiency. These advancements also support the development of personalized medicines and genomics, which require more specialized and customized medicinal ingredients[1].

Biotechnology and Nanotechnology

Breakthroughs in biotechnology and nanotechnology are leading to the creation of novel and more potent medications. These technological advancements are crucial for the development of new pharmaceutical compounds[1].

Rising Prevalence of Chronic Health Issues

The increasing prevalence of chronic health issues such as diabetes and cancer is driving the demand for more effective and specialized pharmaceuticals, which in turn fuels the demand for pharmaceutical chemicals[1].

Regional Market Dynamics

The pharmaceutical chemicals market is geographically diverse, with different regions contributing significantly to its growth.

North America

North America accounted for the largest share of the global pharmaceutical chemicals market in 2022. The region's well-developed healthcare sector and rising awareness of diverse therapeutic applications are key factors driving market growth here[1][4].

Asia Pacific

The Asia Pacific region is emerging as a lucrative market due to the expanding pharmacology and biotechnology industries. India, in particular, is a significant player, meeting 62% of the global vaccine demand and driving indigenous drug development[4].

Segment Analysis

The market can be segmented based on type and drug type.

Type Analysis

The solvents segment is expected to drive demand in the pharmaceutical chemicals market. Other segments, such as reagents and catalysts, also play crucial roles but are anticipated to grow at varying rates[1][4].

Drug Type Analysis

The generic segment is likely to create a significant market for pharmaceutical chemicals. The development of generic drugs often requires a substantial amount of pharmaceutical chemicals, contributing to the market's growth[1].

Financial Performance and Trends

The financial performance of companies in the pharmaceutical chemicals market can be influenced by several factors:

Revenue and Profitability

Companies like Chemtrade Logistics Income Fund have reported mixed financial results. For instance, in the first quarter of 2024, Chemtrade saw a decrease in revenue and Adjusted EBITDA due to lower selling prices for certain products, although higher prices for other products partially offset these declines[2].

Cost Management and Efficiency

Efficient cost management and the optimization of production processes are critical for maintaining profitability. The adoption of green chemistry principles and the integration of digital technologies can help reduce costs and improve the quality of pharmaceutical chemical manufacturing[1].

Investments and Acquisitions

Prominent manufacturers are investing heavily in the development of pharmaceutical intermediates and bioactive compounds. Mergers and acquisitions are also a key strategy for expanding business and market share. For example, JB Chemicals and Pharmaceuticals announced plans to invest over 1500 Cr (approximately US$ 150 million) in acquisitions to grow in India and expand its contract development business[4].

Distribution and Logistics Challenges

Effective distribution and logistics are essential for the pharmaceutical chemicals market.

Complexity of Distribution Systems

The distribution system of pharmaceutical items is complex and dynamic, posing significant challenges to performance and efficiency. Factors such as logistics systems, inventory management, and effective communication between manufacturers, distributors, and health centers are crucial for maintaining a steady supply of pharmaceuticals[3].

Global Health Initiatives

Initiatives like the United Nations Sustainable Development Goal No. 3 emphasize the need to ensure good health and well-being through the accessibility of health supplies. A well-planned and executed distribution system is vital for keeping medicines in good condition, minimizing losses, and ensuring accurate inventory records[3].

Regulatory Landscape

Changes in regulatory landscapes, including quality standards, can impact the production processes and specifications of pharmaceutical chemicals. Companies must adapt to these changes to maintain compliance and ensure the quality of their products[1].

Environmental Concerns

Growing awareness of environmental concerns is driving the adoption of green chemistry principles in the pharmaceutical industry. This shift towards more sustainable practices is expected to influence the market's growth and production methods[1].

Key Takeaways

  • The pharmaceutical chemicals market is projected to grow significantly, driven by increasing healthcare spending, technological advancements, and the rising prevalence of chronic health issues.
  • North America and the Asia Pacific region are key markets, with the latter showing significant growth due to expanding pharmacology and biotechnology industries.
  • Efficient distribution and logistics systems are critical for the market's performance.
  • Companies must adapt to changing regulatory landscapes and environmental concerns to maintain competitiveness.

Frequently Asked Questions

Q: What is the projected growth rate of the pharmaceutical chemicals market from 2023 to 2031? A: The pharmaceutical chemicals market is expected to grow at a CAGR of 5.8% from 2023 to 2031[1][4].

Q: Which region accounted for the largest share of the global pharmaceutical chemicals market in 2022? A: North America accounted for the largest share of the global pharmaceutical chemicals market in 2022[1][4].

Q: What are the key drivers of the pharmaceutical chemicals market? A: Key drivers include increasing healthcare spending, technological advancements, and the rising prevalence of chronic health issues[1].

Q: How do environmental concerns impact the pharmaceutical chemicals market? A: Growing awareness of environmental concerns is driving the adoption of green chemistry principles, influencing production methods and market growth[1].

Q: What role do distribution and logistics play in the pharmaceutical chemicals market? A: Effective distribution and logistics systems are crucial for maintaining a steady supply of pharmaceuticals, minimizing losses, and ensuring accurate inventory records[3].

Sources:

  1. GlobeNewswire: Pharmaceutical Chemicals Market Size to be Worth USD 339.3 billion by 2031 with a Projected CAGR of 5.8%, Says Transparency Market Research Inc.
  2. BusinessWire: Chemtrade Logistics Income Fund Announces Results for the First Quarter of 2024
  3. Emerald Insight: Optimization of dynamics for pharmaceutical distribution
  4. Transparency Market Research: Pharmaceutical Chemicals Market Size, Trends, Analysis to 2031

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.